Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Buy
730,000
+430,100
+143% +$7.98M ﹤0.01% 3111
2025
Q4
$6.08M Buy
+299,900
New +$6.51M ﹤0.01% 3819
2025
Q3
Sell
-150,000
Closed -$2.68M 11023
2025
Q2
$2.68M Sell
150,000
-1,000,000
-87% -$19.5M ﹤0.01% 4511
2025
Q1
$23.8M Buy
+1,150,000
New +$20.7M ﹤0.01% 2161
2024
Q4
Sell
-6,400
Closed -$78K 10484
2024
Q3
$78K Buy
+6,400
New +$53.1K ﹤0.01% 6531
2024
Q1
Sell
-250,000
Closed -$3.65M 10113
2023
Q4
$3.65M Buy
+250,000
New +$3.97M ﹤0.01% 3118
2023
Q2
Sell
-60,000
Closed -$667K 9747
2023
Q1
$667K Buy
60,000
+1,000
+2% +$9.67K ﹤0.01% 4469
2022
Q4
$586K Sell
59,000
-9,400
-14% -$84.7K ﹤0.01% 4567
2022
Q3
$817K Buy
+68,400
New +$1.47M ﹤0.01% 3922
2021
Q4
Sell
-595,000
Closed -$21.1M 10777
2021
Q3
$21.1M Buy
595,000
+375,000
+170% +$14.9M 0.01% 1468
2021
Q2
$9.77M Sell
220,000
-70,000
-24% -$2.39M ﹤0.01% 2054
2021
Q1
$10.6M Buy
290,000
+125,000
+76% +$5.2M ﹤0.01% 1907
2020
Q4
$7.07M Buy
+165,000
New +$6.06M ﹤0.01% 2135

Other funds holding XPEV

UBS Group's XPEV Position: Q1 2026 in Review

UBS Group reduced its XPeng (XPEV) stake by 18% in Q1 2026, selling an estimated $17.4M and leaving 4,404,642 shares worth $75.4M. The position accounts for 0.01% of the portfolio, ranked #1266.

UBS Group first reported a position in XPEV in Q3 2020 and has held it in 23 quarters since. The position peaked at $242M in Q3 2025. 233 funds tracked by Wall St. Rank hold XPEV as of Q1 2026.

  • UBS Group held 4,404,642 shares of XPeng worth $75.4M as of Q1 2026.
  • UBS Group sold 936,572 XPeng shares in Q1 2026, an estimated $17.4M.
  • XPeng made up 0.01% of UBS Group's portfolio in Q1 2026, its #1266 holding.
  • UBS Group first reported a position in XPeng in Q3 2020 and has held it in 23 quarters since.
  • UBS Group's XPeng position peaked at $242M in Q3 2025.
  • 233 funds tracked by Wall St. Rank held XPeng as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.